Trials / Completed
CompletedNCT01651871
Combination Study Of S-555739/Cetirizine HCl In Adult Patients With Seasonal Allergic Rhinitis
A Phase 2, Multicenter, Parallel-Group, Randomized, Double-Blind, Placebo- And Active Comparator-Controlled, Combination Study Of S-555739 And Cetirizine HCl In Adult Patients With Seasonal Allergic Rhinitis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 779 (actual)
- Sponsor
- Shionogi · Industry
- Sex
- All
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of the study was to examine the efficacy and safety of S-555739/cetirizine HCl compared with the individual components and placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | S-555739 Dose 1 | |
| DRUG | S-555739 Dose 2 | |
| DRUG | Cetirizine HCl Dose 1 | |
| DRUG | S-555739 placebo | |
| DRUG | Cetirizine HCl placebo |
Timeline
- Start date
- 2012-07-01
- Primary completion
- 2012-11-01
- Completion
- 2013-05-01
- First posted
- 2012-07-27
- Last updated
- 2018-04-27
Source: ClinicalTrials.gov record NCT01651871. Inclusion in this directory is not an endorsement.